newspaper
civil-litigation
intellectual-property
patent-litigation
real-estate
federal-courts
court-watch
Tanabe Pharma Corporation sues Lupin Limited and others in District of New Jersey
25-cv-16680
D.N.J.
Advertisement
description
Case Summary
TANABE PHARMA CORPORATION has filed a lawsuit against LUPIN LIMITED and others in the District of New Jersey. The case is identified by docket number 25-cv-16680. No current summary is available, and further information is needed to detail the nature of the dispute.
No timeline activity recorded yet. This page will grow as rulings and filings land.
Key Issues
- • Pharmaceutical Litigation
- • Civil Lawsuit
- • Pending Case
smart_toy
Juryvine case summary generated from primary court records.
How we verify our work.
fact_check
Docket Snapshot
account_balance
Court
D.N.J.
District of New Jersey · 3rd Circuit · NJ
tag
Docket
Not captured
Civil
timeline
Stage
Active litigation
Active
event
Filed
Date unavailable
Not in the available feed
new_releases
Latest Filing
2:25-cv-16680 TANABE PHARMA CORPORATION v. LUPIN LIMITED et al
Other · Apr 25, 2026
newspaper
Coverage
1 article
1 source tracked
groups
Participants
1 Defendant, 1 Plaintiff
2 linked entities
gavel
Judge
Not assigned in feed
What the record shows
This case is tied to District of New Jersey, a federal district court in NJ.
The newest docket activity we have is a other dated April 25, 2026.
The visible party/entity graph currently includes Lupin Limited, Tanabe Pharma Corporation.
Press monitoring has found 1 related article from 1 distinct source.
chronic
Updated 4 days, 16 hours ago
The Story So Far
TANABE PHARMA CORPORATION v. LUPIN LIMITED et al is an active civil matter in District of New Jersey under docket 25-cv-16680.
The dispute currently identifies 2:25-cv-16680 TANABE PHARMA CORPORATION on one side and LUPIN LIMITED on the other. The case is currently organized around Current docket activity and next procedural step, Patent validity, infringement, and damages, Real-estate, land-use, or property disputes, Federal jurisdiction and procedural posture.
The available docket gives enough signal to track the case, but not enough to overstate the merits. This page will become more useful as filings, orders, hearings, and party appearances add detail.
On April 25, 2026, the docket recorded a other: The court denied Tanabe Pharma Corporation's motion to seal certain documents in its patent infringement lawsuit against Lupin Limited and others. This decision allows the public to access the documents, which may contain sensitive information about the.
The next thing to watch is whether the latest other produces a substantive order, a scheduling change, a settlement signal, or a filing that clarifies the parties' positions.
smart_toy
Juryvine case narrative generated from the full docket timeline.
How we verify our work.
About This Court
District of New Jersey (D.N.J.) is a federal district court in the 3rd Circuit, NJ.
Advertisement
Case Timeline
1 event
info
Other
April 24, 2026
2:25-cv-16680 TANABE PHARMA CORPORATION v. LUPIN LIMITED et al
The court denied Tanabe Pharma Corporation's motion to seal certain documents in its patent infringement lawsuit against Lupin Limited and others. This decision allows the public to access the documents, which may contain sensitive information about the companies' intellectual property. The ruling has implications for the transparency of patent litigation.
Advertisement
newspaper
1 article
Press Coverage
settings_backup_restore Data provenance expand_more
Sources tracked
1 outlet · 1 article
Timeline events
1 record on file
Last updated
2 days, 20 hours ago
Juryvine aggregates docket entries from PACER/CourtListener, press coverage, and GDELT signals. Ingestion timestamps do not appear in the What Changed feed — that reflects real court activity only.